Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM SM-Reference-Cited by-同舟云学术

Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM SM

Published:2017-02 Issue:1 Volume:15 Page:31-41.e4
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Clark Joseph I.,Wong Michael K.K.,Kaufman Howard L.,Daniels Gregory A.,Morse Michael A.,McDermott David F.,Agarwala Sanjiv S.,Lewis Lionel D.,Stewart John H.,Vaishampayan Ulka,Curti Brendan,Gonzalez René,Lutzky Jose,Rudraptna Venkatesh,Cranmer Lee D.,Jeter Joanne M.^ORCID,Hauke Ralph J.^ORCID,Miletello Gerald,Milhem Mohammed M.,Amin Asim,Richart John M.,Fishman Mayer^ORCID,Hallmeyer Sigrun,Patel Sapna P.,Van Veldhuizen Peter,Agarwal Neeraj,Taback Bret,Treisman Jonathan S.,Ernstoff Marc S.,Perritt Jessica C.,Hua Hong,Rao Tharak B.,Dutcher Janice P.,Aung Sandra

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference25 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Current algorithms and prognostic factors in the treatment of metastatic renal cell carcinoma;Molina;Clin Genitourin Cancer,2008

3. Renal cell carcinoma: current status and future prospects;Drucker;Cancer Treat Rev,2005

4. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial;Escudier;J Clin Oncol,2009

5. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial;Rini;Lancet,2011

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma;Cancer Discovery;2024-04-04

2. Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies;Molecular Cancer;2023-07-29

3. A novel immune-related model to predict prognosis and responsiveness to checkpoint and angiogenesis blockade therapy in advanced renal cancer;Frontiers in Oncology;2023-03-14

4. Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors;Cancer Drug Resistance;2023

5. Clinical Applications of Protein-Based Therapeutics;Protein-based Therapeutics;2023